Lookup NU author(s): Professor Hamish McAllister-Williams,
Dr Eilish Gilvarry,
Dr Laura Yates
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
© British Association for Psychopharmacology. Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.
Author(s): Mcallister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, McDonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH
Publication type: Article
Publication status: Published
Journal: Journal of Psychopharmacology
Online publication date: 25/04/2017
Acceptance date: 02/04/2016
ISSN (print): 0269-8811
ISSN (electronic): 1461-7285
Publisher: Sage Publications Ltd
Altmetrics provided by Altmetric